These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 667864)
1. Systolic time intervals in monitoring adriamycin-induced cardiotoxicity. Balcerzak SP; Christakis J; Lewis RP; Olson HM; Malspeis L Cancer Treat Rep; 1978 Jun; 62(6):893-9. PubMed ID: 667864 [No Abstract] [Full Text] [Related]
2. Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats. Mettler FP; Young DM; Ward JM Cancer Res; 1977 Aug; 37(8 Pt 1):2705-13. PubMed ID: 872096 [No Abstract] [Full Text] [Related]
3. Noninvasive profile in the prospective monitoring of adriamycin cardiomyopathy. Fulkerson PK; Talley R; Kleinman D; Weaver SK; Leier CV; Balcerzak SP; Lewis RP Cancer Treat Rep; 1978 Jun; 62(6):881-6. PubMed ID: 667862 [No Abstract] [Full Text] [Related]
4. Systolic time intervals in monitoring for anthracycline cardiomyopathy in pediatric patients. Hutchinson RJ; Bailey C; Wood D; Donaldson MH Cancer Treat Rep; 1978 Jun; 62(6):907-10. PubMed ID: 667866 [TBL] [Abstract][Full Text] [Related]
5. Subclinical adriamycin cardiotoxicity: detection by timing the arterial sounds. Greco FA Cancer Treat Rep; 1978 Jun; 62(6):901-5. PubMed ID: 667865 [No Abstract] [Full Text] [Related]
6. Systolic time intervals: an effective measure of cardiac function in anthracycline-induced cardiomyopathy of rabbits. Long HJ Cancer Treat Rep; 1978 Jun; 62(6):911-4. PubMed ID: 667867 [TBL] [Abstract][Full Text] [Related]
7. [Possible role of adriamycinol in the cardiotoxicity induced by adriamycin in the rat]. Danesi R; Del Tacca M; Ducci M; Bernardini C; Romanini A G Ital Chemioter; 1985; 32(1):31-3. PubMed ID: 3830790 [No Abstract] [Full Text] [Related]
8. Cardiac toxicity of adriamycin-DNA complex and rubidazone: evaluation by electrocardiogram and endomyocardial biopsy. Benjamin RS; Mason JW; Billingham ME Cancer Treat Rep; 1978 Jun; 62(6):935-9. PubMed ID: 667871 [No Abstract] [Full Text] [Related]
9. Adriamycin cardiotoxicity amelioration by alpha-tocopherol. Krivit W Am J Pediatr Hematol Oncol; 1979; 1(2):151-3. PubMed ID: 543510 [TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of noninvasive cardiac parameters in the detection and evaluation of adriamycin cardiotoxicity. Shuman RD; Ettinger DS; Abeloff MD; Livengood SV; Fortuin NJ Johns Hopkins Med J; 1981 Aug; 149(2):57-63. PubMed ID: 7253365 [TBL] [Abstract][Full Text] [Related]
11. A clinicopathologic analysis of adriamycin cardiotoxicity. Lefrak EA; Pitha J; Rosenheim S; Gottlieb JA Cancer; 1973 Aug; 32(2):302-14. PubMed ID: 4353012 [No Abstract] [Full Text] [Related]
13. Electrocardiographic and biochemical evidence for the cardioprotective effect of vitamin E in doxorubicin-induced acute cardiotoxicity in rats. Puri A; Maulik SK; Ray R; Bhatnagar V Eur J Pediatr Surg; 2005 Dec; 15(6):387-91. PubMed ID: 16418954 [TBL] [Abstract][Full Text] [Related]
14. [Cardiotoxicity of anthracyclines in children. Contribution of anthracyclines in pediatric oncology]. Biron P; Philip T; Bouffet E; Favrot MC; Pinkerton R; Brunat-Mentigny M Pathol Biol (Paris); 1987 Jan; 35(1):97-101. PubMed ID: 3550619 [TBL] [Abstract][Full Text] [Related]
15. Noninvasive monitoring of adriamycin cardiotoxicity by "Sphygmo-Recording" of the pulse wave delay (QKd interval). Greco FA; Brereton HD; Rodbard D Cancer Treat Rep; 1976 Sep; 60(9):1239-45. PubMed ID: 797446 [TBL] [Abstract][Full Text] [Related]